All Blog Posts Tagged 'Long-term' (3)

Early Treatment With Imatinib Offers Significant Long-term Survival Advantage For Patients With Philadelphia Positive Acute Lymphoblastic Leukemia

Over the past decade, significant advances have been made in the treatment of leukemia through the ongoing development of gene-based targeted therapies. Research presented today at the 52nd Annual Meeting of the American Society of Hematology (Orlando, December 4 – 7, 2010) provides greater understanding of the optimal use of several BCR-ABL inhibitors for the treatment of acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia (CML), and how a new gene target functions…

Continue

Added by Peter Hofland, PhD on December 4, 2010 at 9:30pm — No Comments

Childhood Cancer Survivors Face Long-term Risk Of Gastrointestinal Complications, Study From Dana-Farber Finds

People treated for cancer when they were children have a higher-than-average risk of gastrointestinal problems — some mild, some quite severe — in the years following treatment, according to a study to be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Sunday, October 24, 2010.



Investigators at Dana-Farber/Children's Hospital Cancer Center and… Continue

Added by Peter Hofland, PhD on October 22, 2010 at 4:30pm — No Comments

ASCO 2010: Studies Report Advances in Novel Cancer Therapies

Exciting results from studies on some of the latest novel cancer therapies were released today at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held from June 4 - 8 in Chicago, IIllinois (USA).



“The novel therapies presented today could have a major impact on some very hard-totreat cancers, such as those that progress despite all other forms of therapy,” said Lynn Schuchter, MD, professor of medicine at the Abramson Cancer… Continue

Added by Peter Hofland, PhD on June 5, 2010 at 11:30am — No Comments

ADVERTISEMENT

Onco'Zine is present here

© 2013   Created by Peter Hofland, PhD.

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+